Search Results - "Merz AMA"

Multi-site bone marrow core biopsy improves diagnostic accuracy in dogs with hematologic disease.

Authors: Smiley, Kristi M. Connolly, Sara L. Raskin, Rose et al.

Source: PLoS ONE. 2/25/2026, Vol. 21 Issue 2, p1-16. 16p.

Luspatercept and thrombotic events in patients with myelodysplastic syndrome: a target trial emulation framework using TriNetX database.

Authors: Vojjala, Nikhil Nassar, Mahmoud Nanjareddy, Sushmitha et al.

Source: Leukemia & Lymphoma. Jun2026, p1-15. 15p.

High Rates of Seroprotection and Seroconversion to Vaccine-Preventable Infections in the Early Post–Autologous Stem Cell Transplant Period.

Authors: Hall, Victoria G Saunders, Natalie R Klimevski, Emily et al.

Source: Open Forum Infectious Diseases. Oct2023, Vol. 10 Issue 10, p1-5. 5p.

Single-cell technologies in deciphering drug resistance of multiple myeloma: mechanistic insights and clinical translation prospects.

Authors: Wu, Jun Dong, Haibo Xu, Xuejing et al.

Source: Leukemia & Lymphoma. May2026, Vol. 67 Issue 6, p1231-1246. 16p.

Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP‐EBMT study.

Authors: Gagelmann, Nico Eikema, Dirk‐Jan Koster, Linda et al.

Source: European Journal of Haematology. Aug2023, Vol. 111 Issue 2, p181-190. 10p.

Addressing topic modelling via reduced latent space clustering.

Authors: Schiavon, Lorenzo¹, lorenzo.schiavon@unive.it

Source: Statistical Methods & Applications; Mar2025, Vol. 34 Issue 1, p1-20, 20p

Understanding the evolving role of early palliative care in myelodysplastic syndromes: a 2026 narrative review.

Authors: Niscola P Gianfelici V Giovannini M et al.

Source: Annals of hematology [Ann Hematol] 2026 May 04; Vol. 105 (5). Date of Electronic Publication: 2026 May 04.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

Very-low-dose decitabine and rhTPO for thrombocytopenia in lower-risk myelodysplastic syndrome.

Authors: Gao Z Yang F Pan H et al.

Source: Annals of hematology [Ann Hematol] 2026 Apr 21; Vol. 105 (5). Date of Electronic Publication: 2026 Apr 21.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

The role of macrophages and cytokines in the occurrence and development of MDS.

Authors: Li P Li S Guan D et al.

Source: Clinical and experimental medicine [Clin Exp Med] 2026 Mar 08; Vol. 26 (1). Date of Electronic Publication: 2026 Mar 08.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Electronic Cited Medium: Internet ISSN: 1591-9528 (Electronic) Linking ISSN: 15918890 NLM ISO Abbreviation: Clin Exp Med Subsets: MEDLINE

Efficacy and safety of decitabine combined with arsenic trioxide in elderly high-risk myelodysplastic neoplasm patients: a retrospective study.

Authors: Yang, Jianzhong¹ (AUTHOR) diamk1998@163.com

Source: Hematology. Dec2025, Vol. 30 Issue 1, p1-7. 7p.

Construction and validation of a prognostic model of angiogenesis-related genes in multiple myeloma.

Authors: Hu, Rui Chen, Fengyu Yu, Xueting et al.

Source: BMC Cancer. 12/18/2024, Vol. 24 Issue 1, p1-15. 15p.

Phase to phase: Navigating drug combinations with hypomethylating agents in higher-risk MDS trials for optimal outcomes.

Authors: Merz AMA Sébert M Sonntag J et al.

Source: Cancer treatment reviews [Cancer Treat Rev] 2024 Feb; Vol. 123, pp. 102673. Date of Electronic Publication: 2023 Dec 19.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE

Beyond the horizon: emerging therapeutic approaches in myelodysplastic neoplasms.

Authors: Merz AMA Platzbecker U

Source: Experimental hematology [Exp Hematol] 2024 Feb; Vol. 130, pp. 104130. Date of Electronic Publication: 2023 Nov 29.

Publication Type: Review; Journal Article

Journal Info: Publisher: Elsevier Science Inc Country of Publication: Netherlands NLM ID: 0402313 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2399 (Electronic) Linking ISSN: 0301472X NLM ISO Abbreviation: Exp Hematol Subsets: MEDLINE

Optimal timing of allogeneic hematopoietic stem cell transplant in MDS.

Authors: Rathje, Kristin Kröger, Nicolaus

Source: Leukemia & Lymphoma. Oct2025, Vol. 66 Issue 10, p1788-1800. 13p.

Aberrant Kupffer-like differentiation of hematopoietic stem cell is critical for the MDS pathogenesis in Setd2-deficient mice.

Authors: Song J Wang F Xie Y et al.

Source: Cell death and differentiation [Cell Death Differ] 2026 Mar 17. Date of Electronic Publication: 2026 Mar 17.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9437445 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5403 (Electronic) Linking ISSN: 13509047 NLM ISO Abbreviation: Cell Death Differ Subsets: MEDLINE

Dynamic single-cell RNA-seq analysis reveals distinct tumor program associated with microenvironmental remodeling and drug sensitivity in multiple myeloma.

Authors: Chen, Mengping Wan, Yike Li, Xin et al.

Source: Cell & Bioscience. 1/30/2023, Vol. 13 Issue 1, p1-18. 18p.

Advances in the management of higher-risk myelodysplastic syndromes: future prospects.

Authors: Gener-Ricos, Georgina Rodriguez-Sevilla, Juan Jose Urrutia, Samuel et al.

Source: Leukemia & Lymphoma. Sep2024, Vol. 65 Issue 9, p1233-1244. 12p.

Antibody-Drug Conjugates, T-Cell Engager Bispecific Antibodies and Chimeric Antigen Receptor T Cells for Multiple Myeloma: What's the Current Status?

Authors: Segers F Delforge M

Source: Targeted oncology [Target Oncol] 2026 Jan; Vol. 21 (1), pp. 63-86. Date of Electronic Publication: 2026 Jan 21.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE

Engineering TCR-directed T-cells for the treatment of multiple myeloma.

Authors: Mubin N Ignatz-Hoover JJ Driscoll JJ

Source: Frontiers in immunology [Front Immunol] 2026 Mar 31; Vol. 17, pp. 1755096. Date of Electronic Publication: 2026 Mar 31 (Print Publication: 2026).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Novel immunotargets in multiple myeloma: biological relevance and therapeutic potential.

Authors: Kotulová J Baďurová K Chyra Z et al.

Source: Biomarker research [Biomark Res] 2025 Jul 01; Vol. 13 (1), pp. 92. Date of Electronic Publication: 2025 Jul 01.

Publication Type: Journal Article; Review

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101607860 Publication Model: Electronic Cited Medium: Print ISSN: 2050-7771 (Print) Linking ISSN: 20507771 NLM ISO Abbreviation: Biomark Res Subsets: PubMed not MEDLINE